– USA, IL – Nexus Pharmaceuticals LLC, a healthcare company today announced the appointments of Edgar Lee and Mike Warmuth to its Board of Directors, effective immediately.
“We look forward to the guidance of our new members, who will help Nexus continue to grow and meet the demands of a changing healthcare landscape. They bring with them a wealth of experience and a deep understanding of our mission, which will be invaluable as we continue to innovate and expand our services.” said Founder and Board Chair, Mariam Darsot.
About Edgar Lee
Mr. Lee is the Founder and Managing Member of Sagent Group and brings over twenty years of experience investing in and advising companies in the life sciences and technology, media, and telecommunications industries. Before the founding of Sagent Group, he served as the founder and portfolio manager of Oaktree’s $6 billion Strategic Credit strategy and as CEO and CIO of the organization’s three business development companies. Mr. Lee also brings experience from his work in TMT investment banking at UBS in Los Angeles, fixed income at Lehman Brothers, management consulting at Katzenbach Partners (Booz & Co.), and economic research at the Urban Institute.
Edgar Lee holds a B.A. degree in economics from Swarthmore College and a master’s degree from Harvard University.
About Mike Warmuth
Mr. Warmuth was most recently an Operating Partner at EW Healthcare Partners from 2018 to 2022. Prior to EW Healthcare Partners, Mr. Warmuth was at Abbott Laboratories, where he led the Established Pharmaceuticals division which soon became one of the top ten largest generics companies across the globe and covered several therapeutic areas including gastroenterology, women’s health, cardiovascular, and metabolic disorders. His work at Abbott reflects a strong track record of success in driving operational excellence and growth through mergers and acquisitions.
Mike Warmuth holds a B.A. degree in Business Administration from the University of Wisconsin-Whitewater and a master’s degree from Northwestern University.
About Nexus Pharmaceuticals LLC
Nexus Pharmaceuticals LLC, a US-based healthcare company and certified diverse supplier, specializes in innovative processes to make difficult-to-manufacture specialty and generic drugs that are easier to use, less labor-intensive, and more streamlined in practice. Nexus ensures that its high-quality FDA-approved drugs fulfill a critical unmet medical need and delivers dependable life-saving treatment options when and where they’re needed most.
For more information: https://www.nexuspharma.net/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
